Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 45 | 2025 | 315 | 7.530 |
Why?
|
| Isocyanates | 19 | 2022 | 46 | 3.890 |
Why?
|
| Nanoparticles | 23 | 2025 | 523 | 3.000 |
Why?
|
| Environmental Pollutants | 4 | 2025 | 95 | 2.310 |
Why?
|
| Inhalation Exposure | 14 | 2020 | 55 | 2.300 |
Why?
|
| Fluorocarbons | 4 | 2025 | 44 | 2.190 |
Why?
|
| Polyurethanes | 9 | 2022 | 29 | 2.090 |
Why?
|
| Air Pollutants, Occupational | 14 | 2025 | 74 | 2.040 |
Why?
|
| Titanium | 8 | 2025 | 62 | 1.790 |
Why?
|
| Air Pollutants | 11 | 2023 | 94 | 1.790 |
Why?
|
| Nanostructures | 7 | 2018 | 181 | 1.690 |
Why?
|
| Environmental Monitoring | 21 | 2025 | 149 | 1.560 |
Why?
|
| Epoxy Resins | 3 | 2024 | 4 | 1.460 |
Why?
|
| Oxidative Stress | 9 | 2023 | 304 | 1.420 |
Why?
|
| Environmental Exposure | 3 | 2025 | 220 | 1.410 |
Why?
|
| Paint | 9 | 2024 | 22 | 1.290 |
Why?
|
| Printing | 8 | 2025 | 21 | 1.140 |
Why?
|
| Construction Industry | 3 | 2024 | 19 | 1.000 |
Why?
|
| Skin Absorption | 7 | 2016 | 16 | 0.970 |
Why?
|
| Skin | 7 | 2020 | 386 | 0.970 |
Why?
|
| Air Pollution, Indoor | 7 | 2017 | 37 | 0.930 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2021 | 147 | 0.910 |
Why?
|
| Copying Processes | 5 | 2024 | 10 | 0.900 |
Why?
|
| Avena | 1 | 2024 | 7 | 0.900 |
Why?
|
| Capsid Proteins | 1 | 2025 | 103 | 0.890 |
Why?
|
| Capsid | 1 | 2025 | 97 | 0.890 |
Why?
|
| beta-Glucans | 1 | 2024 | 56 | 0.860 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 239 | 0.850 |
Why?
|
| Dietary Fiber | 1 | 2024 | 77 | 0.840 |
Why?
|
| Nanotubes, Carbon | 6 | 2016 | 19 | 0.840 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 38 | 0.780 |
Why?
|
| Automobiles | 8 | 2008 | 66 | 0.780 |
Why?
|
| Toxicity Tests | 3 | 2018 | 18 | 0.770 |
Why?
|
| Biomarkers | 9 | 2025 | 1431 | 0.760 |
Why?
|
| Gastrointestinal Tract | 3 | 2019 | 187 | 0.750 |
Why?
|
| Inflammation | 4 | 2025 | 1162 | 0.730 |
Why?
|
| Occupational Diseases | 5 | 2024 | 267 | 0.700 |
Why?
|
| Manufacturing Industry | 2 | 2017 | 3 | 0.650 |
Why?
|
| Benzhydryl Compounds | 7 | 2024 | 61 | 0.630 |
Why?
|
| Workplace | 7 | 2021 | 174 | 0.620 |
Why?
|
| Genetic Vectors | 1 | 2025 | 887 | 0.610 |
Why?
|
| Food Additives | 2 | 2022 | 27 | 0.610 |
Why?
|
| Humans | 68 | 2025 | 64272 | 0.610 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 85 | 0.600 |
Why?
|
| Dependovirus | 1 | 2025 | 718 | 0.600 |
Why?
|
| Hazardous Substances | 4 | 2024 | 15 | 0.590 |
Why?
|
| Dipeptides | 1 | 2019 | 68 | 0.580 |
Why?
|
| Gastric Juice | 1 | 2018 | 9 | 0.580 |
Why?
|
| Flame Retardants | 1 | 2018 | 6 | 0.560 |
Why?
|
| Organophosphates | 1 | 2018 | 16 | 0.560 |
Why?
|
| Particle Size | 14 | 2020 | 421 | 0.550 |
Why?
|
| Particulate Matter | 6 | 2019 | 65 | 0.540 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 65 | 0.510 |
Why?
|
| Metal Nanoparticles | 2 | 2017 | 188 | 0.490 |
Why?
|
| Liver | 3 | 2025 | 868 | 0.490 |
Why?
|
| Pilot Projects | 3 | 2025 | 1020 | 0.450 |
Why?
|
| Engineering | 1 | 2014 | 10 | 0.440 |
Why?
|
| Dust | 7 | 2024 | 41 | 0.430 |
Why?
|
| Construction Materials | 3 | 2024 | 14 | 0.430 |
Why?
|
| Materials Testing | 4 | 2019 | 86 | 0.420 |
Why?
|
| Singapore | 3 | 2023 | 14 | 0.410 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 237 | 0.400 |
Why?
|
| Nanotechnology | 1 | 2014 | 135 | 0.400 |
Why?
|
| Aerosols | 2 | 2012 | 47 | 0.390 |
Why?
|
| Epoxy Compounds | 2 | 2024 | 11 | 0.390 |
Why?
|
| Animals | 20 | 2025 | 20955 | 0.390 |
Why?
|
| Environmental Health | 1 | 2012 | 15 | 0.380 |
Why?
|
| Metals | 4 | 2020 | 64 | 0.350 |
Why?
|
| Protective Clothing | 3 | 2024 | 29 | 0.340 |
Why?
|
| Printing, Three-Dimensional | 3 | 2023 | 40 | 0.340 |
Why?
|
| Cyanates | 2 | 2007 | 4 | 0.330 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 4 | 2014 | 44 | 0.320 |
Why?
|
| DNA Damage | 4 | 2016 | 289 | 0.320 |
Why?
|
| Occupational Health | 5 | 2025 | 187 | 0.320 |
Why?
|
| Mice | 9 | 2025 | 10994 | 0.320 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 129 | 0.310 |
Why?
|
| Dermatitis, Occupational | 2 | 2016 | 4 | 0.310 |
Why?
|
| Quartz | 4 | 2011 | 8 | 0.310 |
Why?
|
| Water Pollutants, Chemical | 3 | 2025 | 43 | 0.300 |
Why?
|
| New England | 2 | 2020 | 269 | 0.300 |
Why?
|
| Food Safety | 2 | 2019 | 10 | 0.300 |
Why?
|
| Personal Protective Equipment | 2 | 2020 | 32 | 0.290 |
Why?
|
| Triazines | 2 | 2006 | 21 | 0.290 |
Why?
|
| Cell Line | 7 | 2025 | 2057 | 0.290 |
Why?
|
| Silicon Dioxide | 2 | 2019 | 62 | 0.290 |
Why?
|
| Male | 14 | 2025 | 30322 | 0.270 |
Why?
|
| Cytokines | 5 | 2021 | 945 | 0.260 |
Why?
|
| Asthma | 3 | 2024 | 471 | 0.260 |
Why?
|
| Dermatitis, Contact | 2 | 2024 | 12 | 0.240 |
Why?
|
| Graphite | 2 | 2016 | 15 | 0.240 |
Why?
|
| Dermatitis | 1 | 2006 | 28 | 0.240 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2025 | 24 | 0.240 |
Why?
|
| Nanofibers | 2 | 2016 | 19 | 0.240 |
Why?
|
| Alkanesulfonic Acids | 1 | 2025 | 6 | 0.230 |
Why?
|
| Air Microbiology | 1 | 2025 | 11 | 0.230 |
Why?
|
| Oxides | 4 | 2019 | 36 | 0.230 |
Why?
|
| Decontamination | 1 | 2005 | 13 | 0.230 |
Why?
|
| Gloves, Protective | 4 | 2019 | 7 | 0.230 |
Why?
|
| Detergents | 1 | 2005 | 34 | 0.230 |
Why?
|
| Trichloroethylene | 1 | 2025 | 1 | 0.230 |
Why?
|
| Polymers | 2 | 2006 | 327 | 0.230 |
Why?
|
| Inulin | 1 | 2024 | 3 | 0.230 |
Why?
|
| Body Burden | 1 | 2024 | 11 | 0.230 |
Why?
|
| Azides | 1 | 2025 | 21 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2025 | 37 | 0.220 |
Why?
|
| Canada | 1 | 2025 | 151 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2025 | 71 | 0.220 |
Why?
|
| Cell Survival | 6 | 2019 | 582 | 0.220 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2024 | 5 | 0.210 |
Why?
|
| Surface Properties | 4 | 2019 | 281 | 0.210 |
Why?
|
| Macrophages | 5 | 2019 | 1053 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2025 | 91 | 0.210 |
Why?
|
| Lactoferrin | 1 | 2024 | 37 | 0.210 |
Why?
|
| Adult | 10 | 2025 | 17136 | 0.210 |
Why?
|
| Risk Assessment | 6 | 2019 | 2048 | 0.210 |
Why?
|
| Industry | 4 | 2015 | 60 | 0.200 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2023 | 19 | 0.200 |
Why?
|
| Lung | 4 | 2016 | 964 | 0.190 |
Why?
|
| Tyrosine | 1 | 2023 | 94 | 0.190 |
Why?
|
| Zinc | 2 | 2021 | 93 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2019 | 386 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2024 | 239 | 0.190 |
Why?
|
| Cocaine | 1 | 2023 | 101 | 0.190 |
Why?
|
| Ethanol | 1 | 2025 | 325 | 0.180 |
Why?
|
| Bacterial Translocation | 1 | 2021 | 10 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3449 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 388 | 0.180 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 54 | 0.180 |
Why?
|
| Ferric Compounds | 2 | 2018 | 44 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 252 | 0.180 |
Why?
|
| Virulence Factors | 1 | 2021 | 85 | 0.170 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 108 | 0.170 |
Why?
|
| Biofilms | 1 | 2021 | 83 | 0.160 |
Why?
|
| Silanes | 1 | 2019 | 3 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 6 | 2017 | 136 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 243 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2021 | 192 | 0.160 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 86 | 0.150 |
Why?
|
| Recycling | 2 | 2016 | 4 | 0.150 |
Why?
|
| Glutathione | 1 | 2019 | 56 | 0.150 |
Why?
|
| Middle Aged | 5 | 2025 | 17923 | 0.150 |
Why?
|
| Motor Vehicles | 2 | 2012 | 32 | 0.150 |
Why?
|
| Zinc Oxide | 1 | 2018 | 6 | 0.140 |
Why?
|
| Diet | 1 | 2022 | 533 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 327 | 0.140 |
Why?
|
| Female | 8 | 2025 | 33383 | 0.140 |
Why?
|
| Elephantiasis | 1 | 2017 | 1 | 0.130 |
Why?
|
| Biological Availability | 1 | 2018 | 204 | 0.130 |
Why?
|
| Hemolysis | 1 | 2017 | 40 | 0.130 |
Why?
|
| Soil | 1 | 2017 | 26 | 0.130 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2016 | 7 | 0.130 |
Why?
|
| Malondialdehyde | 1 | 2016 | 16 | 0.130 |
Why?
|
| Breath Tests | 1 | 2016 | 14 | 0.130 |
Why?
|
| Chemical Industry | 1 | 2016 | 8 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 19 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2019 | 869 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 63 | 0.130 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2017 | 72 | 0.120 |
Why?
|
| Volatile Organic Compounds | 2 | 2014 | 20 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2013 | 33 | 0.120 |
Why?
|
| Polypropylenes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Temperature | 1 | 2017 | 312 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 12 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 744 | 0.120 |
Why?
|
| Toxicology | 1 | 2015 | 30 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2016 | 230 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 223 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 93 | 0.110 |
Why?
|
| Nanopores | 1 | 2014 | 14 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 319 | 0.110 |
Why?
|
| Hypersensitivity | 2 | 2024 | 65 | 0.110 |
Why?
|
| Serum | 2 | 2011 | 27 | 0.100 |
Why?
|
| Antioxidants | 2 | 2017 | 256 | 0.100 |
Why?
|
| Ink | 1 | 2013 | 10 | 0.100 |
Why?
|
| Apoptosis | 3 | 2013 | 1095 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2015 | 294 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 267 | 0.100 |
Why?
|
| Synapses | 1 | 2015 | 191 | 0.100 |
Why?
|
| Permeability | 2 | 2025 | 50 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2015 | 417 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 312 | 0.100 |
Why?
|
| Welding | 2 | 2010 | 4 | 0.090 |
Why?
|
| Models, Biological | 2 | 2015 | 1187 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2012 | 46 | 0.090 |
Why?
|
| Asthma, Occupational | 1 | 2012 | 2 | 0.090 |
Why?
|
| United States | 4 | 2020 | 7923 | 0.090 |
Why?
|
| Noise, Occupational | 1 | 2011 | 14 | 0.090 |
Why?
|
| Nitriles | 2 | 2024 | 79 | 0.090 |
Why?
|
| Aluminum | 1 | 2010 | 14 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1494 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 251 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 163 | 0.080 |
Why?
|
| Young Adult | 4 | 2025 | 4782 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2011 | 127 | 0.070 |
Why?
|
| Aged | 1 | 2025 | 14663 | 0.070 |
Why?
|
| Neurons | 1 | 2015 | 934 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2017 | 401 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 58 | 0.070 |
Why?
|
| Respiratory Protective Devices | 1 | 2006 | 13 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2006 | 84 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 183 | 0.060 |
Why?
|
| Porphyromonas | 1 | 2025 | 1 | 0.060 |
Why?
|
| Chryseobacterium | 1 | 2025 | 1 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Propylene Glycols | 1 | 2005 | 9 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 97 | 0.060 |
Why?
|
| Candida | 1 | 2025 | 41 | 0.060 |
Why?
|
| Tetrachloroethylene | 1 | 2025 | 1 | 0.060 |
Why?
|
| Acetylene | 1 | 2025 | 3 | 0.060 |
Why?
|
| Feces | 1 | 2025 | 116 | 0.060 |
Why?
|
| Maximum Allowable Concentration | 1 | 2004 | 3 | 0.060 |
Why?
|
| Carcinogens | 1 | 2024 | 36 | 0.060 |
Why?
|
| Boston | 2 | 2002 | 255 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2016 | 93 | 0.060 |
Why?
|
| Consumer Product Safety | 2 | 2014 | 12 | 0.060 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2024 | 26 | 0.050 |
Why?
|
| Chemical Phenomena | 2 | 2014 | 96 | 0.050 |
Why?
|
| Latex | 1 | 2024 | 5 | 0.050 |
Why?
|
| Kinetics | 1 | 2006 | 766 | 0.050 |
Why?
|
| Neoplasms | 2 | 2024 | 1393 | 0.050 |
Why?
|
| Comet Assay | 2 | 2013 | 11 | 0.050 |
Why?
|
| Fatigue | 1 | 2024 | 114 | 0.050 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Microbiota | 1 | 2025 | 136 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 462 | 0.050 |
Why?
|
| Hydrocodone | 1 | 2023 | 7 | 0.050 |
Why?
|
| Amphetamine | 1 | 2023 | 12 | 0.050 |
Why?
|
| Carbon | 2 | 2015 | 53 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 42 | 0.050 |
Why?
|
| Vehicle Emissions | 1 | 2002 | 23 | 0.050 |
Why?
|
| Fentanyl | 1 | 2023 | 75 | 0.050 |
Why?
|
| Methadone | 1 | 2023 | 136 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 71 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 2005 | 0.040 |
Why?
|
| Rural Population | 1 | 2023 | 212 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1270 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2177 | 0.040 |
Why?
|
| Body Weight | 1 | 2022 | 379 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 1561 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 3725 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 55 | 0.040 |
Why?
|
| Textiles | 1 | 2019 | 10 | 0.040 |
Why?
|
| Holistic Health | 1 | 2019 | 12 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 178 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 676 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2237 | 0.030 |
Why?
|
| Chromans | 1 | 2017 | 16 | 0.030 |
Why?
|
| Catalase | 1 | 2017 | 23 | 0.030 |
Why?
|
| Chromium | 1 | 2017 | 5 | 0.030 |
Why?
|
| Barium | 1 | 2017 | 7 | 0.030 |
Why?
|
| Ethiopia | 1 | 2017 | 9 | 0.030 |
Why?
|
| Manganese Compounds | 1 | 2017 | 8 | 0.030 |
Why?
|
| Calcium Compounds | 1 | 2017 | 5 | 0.030 |
Why?
|
| Minerals | 1 | 2017 | 20 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 62 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 501 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2621 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 848 | 0.030 |
Why?
|
| Polycarboxylate Cement | 1 | 2016 | 4 | 0.030 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2016 | 9 | 0.030 |
Why?
|
| Suspensions | 1 | 2015 | 9 | 0.030 |
Why?
|
| Research | 1 | 2017 | 196 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 171 | 0.030 |
Why?
|
| Computer Systems | 1 | 2015 | 14 | 0.030 |
Why?
|
| Paper | 1 | 2015 | 13 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 139 | 0.030 |
Why?
|
| Connecticut | 2 | 2006 | 87 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 92 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 498 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 20 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6306 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 110 | 0.030 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2014 | 2 | 0.030 |
Why?
|
| Research Design | 2 | 2010 | 583 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 111 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 625 | 0.030 |
Why?
|
| Ozone | 1 | 2014 | 18 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2015 | 203 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 156 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1682 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2014 | 139 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 608 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2013 | 99 | 0.030 |
Why?
|
| Albumins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 56 | 0.030 |
Why?
|
| Algorithms | 2 | 2008 | 1029 | 0.020 |
Why?
|
| Solubility | 1 | 2013 | 189 | 0.020 |
Why?
|
| Nasal Lavage Fluid | 1 | 2012 | 7 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 18 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 668 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 891 | 0.020 |
Why?
|
| Zymosan | 1 | 2011 | 25 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 53 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 332 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2011 | 34 | 0.020 |
Why?
|
| Friction | 1 | 2010 | 4 | 0.020 |
Why?
|
| Alloys | 1 | 2010 | 30 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2011 | 266 | 0.020 |
Why?
|
| Iron | 1 | 2010 | 154 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 194 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 303 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 39 | 0.020 |
Why?
|
| Developing Countries | 1 | 2008 | 94 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2370 | 0.020 |
Why?
|
| Colorimetry | 1 | 2007 | 26 | 0.020 |
Why?
|
| Safety Management | 1 | 2008 | 137 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3068 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2004 | 34 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 384 | 0.010 |
Why?
|
| Facility Design and Construction | 1 | 2002 | 11 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2002 | 61 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 5341 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2738 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1164 | 0.010 |
Why?
|